Farminveste, S.G.P.S., S.A. (MLFMV) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Farminveste, S.G.P.S., S.A. stock €7.55, price €5.00, upside +51.0%, quality 51 out of 100. Rating: strongly undervalued. Calculated from audited financials with 24 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 9, 2026.
How to read this chart
60‑month range €1.10 – €5.55 · fair‑value band €5.07 – €10.44 · the €5.00 price screens below the €7.55 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 9, 2026.
Follow Farminveste, S.G.P.S. in your weekly email
Every Wednesday you see whether Farminveste, S.G.P.S. is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Farminveste, S.G.P.S., S.A., through its subsidiaries, engages in the pharmacies and pharmaceutical distribution in Portugal and internationally.
Show moreShow less
The company distributes pharmaceutical products; operates hospitals and clinics; and offers consultancy and technological services in the healthcare sector. It is also involved in information technologies, healthcare, health market intelligence, real estate, and other services businesses.
In addition, the company is involved in the market research study in the health area; and operation of pharmacies. Further, it invests in the real estate sector. The company was incorporated in 2010 and is based in Lisbon, Portugal.
Farminveste, S.G.P.S., S.A. operates as a subsidiary of Associacao Nacional das Farmacias.
Stock analysis
Farminveste, S.G.P.S., S.A. (MLFMV) currently trades at €5.00, while our model-based Fair Value estimate is €7.55, implying the stock looks roughly 34% undervalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of €49.89 per share, and 17 of the 24 models we run sit above the €5.00 price.
Bear case: the Asset-Based group reads lowest at €1.69, and 7 of the 24 models stay below the price. Data coverage for this calculation is medium.
Scenario range: €5.07 (bear) to €10.44 (bull), the price of €5.00 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 51/100 (solid quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Farminveste, S.G.P.S., S.A. reported revenue of €909M in FY2025 versus €799M in FY2021, a compound +3.3%/yr. Reported net income was €58.7M in FY2025, compounding +135.3%/yr from FY2021. FY2021 was a trough year, so the rate overstates the trend.
Key figures
Market cap €101M Micro · P/E ratio 4.0 · P/S ratio 0.11 · EPS (TTM) €1.26 · Dividend yield 13.2% · Net margin 2.7% · Return on equity 10.2% · Return on assets (EBIT) 4.5% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 39 out of 100 (low confidence).
What moves the price
The share trades about 10% below its 52-week high and 67% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 33% fair-value upside, at 51%, MLFMV screens cheaper than that median.
Fair Value models
Bear€5.07Fair Value €7.55Bull€10.44
Price €5.00 · Upside +51.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (€1.08 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF€5.48€7.50€9.8580
Growth DCF€5.60€7.45€9.5379
Owner Earnings€25.61€32.98€41.5677
All 24 models by family
DCF Models
FCF DCF€5.48€7.50€9.8580
Owner Earnings€25.61€32.98€41.5677
5Y Revenue Exit€3.86€5.94€8.4671
5Y EBITDA Exit€6.52€10.58€15.0974
5Y P/E Exit€23.87€40.77€57.6569
10Y Revenue Exit€4.45€6.24€8.2666
10Y EBITDA Exit€5.96€8.88€12.2868
10Y P/E Exit€15.15€26.08€38.0462
Earnings-Based
Graham-Dodd€19.78€40.56€51.1566
EPV€1.04€1.41€1.7273
Dividend Discount
Gordon GGM€2.71€3.59€4.3569
DDM Multi-Stage€2.71€3.51€4.2767
Multiples
P/E Multiple€47.99€63.99€79.9963
P/S Multiple€37.09€49.45€61.8157
P/B Multiple€2.61€3.48€4.3555
EV/EBIT€3.60€5.91€8.2263
EV/EBITDA€7.66€11.32€14.9966
EV/Revenue€1.62€3.74€5.8650
Asset-Based
NCAV (Graham)€1.26€1.69€2.5253
Growth DCF
Growth DCF€5.60€7.45€9.5379
Rev-Margin DCF€3.86€6.10€8.5471
Economic Profit
Residual Income€13.62€16.48€22.7175
ROIC Compounder€1.04€1.41€1.7271
Growth Earnings
Growth-Adj P/E€34.92€49.89€64.8567
The fair value above starts from this blend and is adjusted for dilution from new shares.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.51/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+7.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.0%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.5%
Start year 2020 (pandemic). Over 10 years: +2.8% a year
Revenue growth 10 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.8%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
≈ +64.5%
Earnings growth per share plus dividend.
Earnings per share, growth per year+51.3%
Dividend (yield on the price)13.2%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.51.3% vs 11.6%, picking up
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.0% → 2%
Pace: the 5-year rate starts in 2020 (pandemic)
⚠ Approximate: the rate leans on 2025, which sits 464% above its own trend.
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−9.0%
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect
n/a
No analyst forecast available.
After inflation (euro area: IMF forecast 2.2% a year to 2030, 2.6% from 2016 to 2025) that is about −10.9% a year for the price.
Compare Farminveste, S.G.P.S., S.A. with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Distribution · 77 stocks
Beats the industry median on 11/14 measures
Overall it ranks above its industry peers.
Valuation
Quality Score51 · Below median
Fair Value upside+51.0% · Above median
Profitability
Return on equity (12 months)10.2% · Above median
Return on assets9.8% · Top 25%
Net margin (12 months)2.7% · Above median
Operating margin (12 months)2.6% · Below median
Growth and dividend
Revenue growth (quarter YoY)7.8% · Above median
Dividend yield (12 months)13.2% · Top 25%
Balance sheet
Debt / equity0.45× · Highest 25%
Valuation Multiplesvs Medical Distribution median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Farminveste, S.G.P.S., S.A. (MLFMV) overvalued or undervalued?
As of Nov 9, 2026, our model estimates a fair value of €7.55 versus a price of €5.00, about +51% upside (undervalued).
What is the fair value of MLFMV?
Our model-based fair value for Farminveste, S.G.P.S., S.A. is €7.55 (as of Nov 9, 2026), built from audited fundamentals. The current price: €5.00.
What is the quality score of MLFMV?
Farminveste, S.G.P.S., S.A. has a Quality Score of 51/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Farminveste, S.G.P.S., S.A. (MLFMV)?
Our model-based price target is the fair value of €7.55 (as of Nov 9, 2026) from 24 valuation models. Cautious scenario €5.07, optimistic scenario €10.44. It is a calculation from audited fundamentals, not an analyst target.
What is the Farminveste, S.G.P.S., S.A. stock forecast for 2026?
Our models put fair value at €7.55, about +51% upside versus a price of €5.00 (undervalued). Cautious scenario €5.07, optimistic scenario €10.44. The calculation is refreshed regularly with new filings.
What is the revenue of Farminveste, S.G.P.S., S.A. (MLFMV)?
Farminveste, S.G.P.S., S.A. reported trailing-twelve-month revenue of about €946M (latest available figure, as of Nov 9, 2026).
Does Farminveste, S.G.P.S., S.A. pay a dividend?
Farminveste, S.G.P.S., S.A. currently shows a dividend yield of 13.24% relative to its recent price (as of Nov 9, 2026).
How much is the dividend of Farminveste, S.G.P.S., S.A. (MLFMV)?
Farminveste, S.G.P.S., S.A. has a dividend yield of 13.2%.
What growth is priced into Farminveste, S.G.P.S., S.A. (MLFMV)?
For today's price to be fair in a discounted-cash-flow model, Farminveste, S.G.P.S., S.A. would have to grow free cash flow by -9.0 % per year for five years (discount rate 12.6 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +3.5 % per year. As of Nov 9, 2026.
What discount rate (WACC) does the fair value of MLFMV use?
Our models discount Farminveste, S.G.P.S., S.A. at 12.6 %: a base by market capitalisation (micro), damped by beta 0.49, country premium for Portugal. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Farminveste, S.G.P.S., S.A. that is -9.0 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (12.6 %) and the same formula as our fair value.
How much growth has Farminveste, S.G.P.S., S.A. (MLFMV) delivered so far?
Over the past 5 years revenue at Farminveste, S.G.P.S., S.A. grew +3.5 % a year. The price currently implies free-cash-flow growth of -9.0 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Farminveste, S.G.P.S., S.A. (MLFMV) growing?
The median revenue growth in the sector is +1.7 % a year. That is the yardstick for the growth priced into Farminveste, S.G.P.S., S.A. (-9.0 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Farminveste, S.G.P.S., S.A. (MLFMV)?
The free-cash-flow yield on the price is 24.57 %: that much free cash flow Farminveste, S.G.P.S., S.A. produces per unit of market value. When it exceeds the discount rate of our models (12.6 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Farminveste, S.G.P.S., S.A. (MLFMV)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Farminveste, S.G.P.S., S.A. it is €7.55 per share (as of Nov 9, 2026), against a price of €5.00. It is the blended result of 24 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Farminveste, S.G.P.S., S.A. stock overvalued or undervalued in 2026?
As of Nov 9, 2026, MLFMV trades below its calculated fair value: price €5.00, fair value €7.55, a gap of about +51% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of MLFMV?
No. The price is what the market pays today (€5.00); the fair value is what the company's own numbers justify (€7.55). For Farminveste, S.G.P.S., S.A. the two are €2.55 per share apart. That gap is exactly why we show both numbers side by side.
How much is Farminveste, S.G.P.S., S.A. worth?
The market values Farminveste, S.G.P.S., S.A. at about €101M (market capitalisation, as of Nov 9, 2026). Per share that is €5.00; our models calculate a fair value of €7.55 per share.
What do the bullish and bearish scenarios say about MLFMV?
Our models span a range for Farminveste, S.G.P.S., S.A.: cautious scenario €5.07, base €7.55, optimistic €10.44 per share (as of Nov 9, 2026, price €5.00). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of MLFMV?
Farminveste, S.G.P.S., S.A. trades at a price-to-earnings ratio of 4.0 (as of Nov 9, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of €7.55 is built from several models across several years. Median P/E at fiscal year-end, 7 fiscal years (2018 to 2025), reported earnings: 7.7. Other multiples: P/B 0.5, P/S 0.1, EV/EBITDA 6.4.
How solid is the balance sheet of Farminveste, S.G.P.S., S.A. (MLFMV)?
Balance-sheet figures for Farminveste, S.G.P.S., S.A. (as of Nov 9, 2026): return on equity 10.2%, debt of 0.45 per unit of equity. They feed the Quality Score of 51/100, which measures business quality independently of the share price.
How far is MLFMV from its 52-week high?
Farminveste, S.G.P.S., S.A. trades at €5.00, about 10% below its 52-week high of €5.55 and 67% above the low of €3.00 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of €7.55 is for.
Which stocks are comparable to Farminveste, S.G.P.S., S.A.?
From the same area (Healthcare) we also value McKesson Corporation, Cencora, Inc, Cardinal Health, Inc, Henry Schein, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Farminveste, S.G.P.S., S.A. stock attractive at the current price?
The data as of Nov 9, 2026: price €5.00, calculated fair value €7.55 (+51%), Quality Score 51/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of MLFMV calculated?
We run Farminveste, S.G.P.S., S.A. through 24 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of €7.55 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Farminveste, S.G.P.S., S.A. currently trades 34% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Farminveste, S.G.P.S., S.A. (MLFMV)?
The closing price on Nov 6, 2026 was €5.00. Our model-based fair value is €7.55, about +51% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Farminveste, S.G.P.S., S.A. right now?
Solid quality (51/100) at a price below fair value, the discount is the argument here, not the business quality. A fairly wide model range (€5.07 to €10.44) leaves room in how you read the outcome.
Key figures of Farminveste, S.G.P.S., S.A.
How large is the market capitalisation of Farminveste, S.G.P.S., S.A. (MLFMV)?
The market capitalisation of Farminveste, S.G.P.S., S.A. is €101M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Farminveste, S.G.P.S., S.A. (MLFMV)?
The price-to-sales ratio of Farminveste, S.G.P.S., S.A. is 0.11 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Farminveste, S.G.P.S., S.A. (MLFMV)?
Earnings per share at Farminveste, S.G.P.S., S.A. are €1.26 (price ÷ EPS = P/E 4.0). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Farminveste, S.G.P.S., S.A. (MLFMV)?
The dividend yield of Farminveste, S.G.P.S., S.A. is 13.2% (payout 52.6%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Farminveste, S.G.P.S., S.A. (MLFMV)?
The net margin of Farminveste, S.G.P.S., S.A. is 2.7% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Farminveste, S.G.P.S., S.A. (MLFMV)?
The return on equity (ROE) of Farminveste, S.G.P.S., S.A. is 10.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Farminveste, S.G.P.S., S.A. (MLFMV)?
On an EBIT basis the return on assets of Farminveste, S.G.P.S., S.A. is 4.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Farminveste, S.G.P.S., S.A. (MLFMV)?
The operating margin of Farminveste, S.G.P.S., S.A. is 2.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Farminveste, S.G.P.S., S.A. (MLFMV)?
Revenue at Farminveste, S.G.P.S., S.A. is growing +7.8% versus a year earlier (3y avg +3.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Farminveste, S.G.P.S., S.A. (MLFMV)?
Earnings per share at Farminveste, S.G.P.S., S.A. are growing −69.8% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Farminveste, S.G.P.S., S.A. (MLFMV) carry?
The net debt of Farminveste, S.G.P.S., S.A. is €114M (fiscal year 2025, ≈ 4.6 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Farminveste, S.G.P.S., S.A. in the live analysis
One click puts Farminveste, S.G.P.S., S.A. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Some data
Nov 9, 2026